Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 1
2006 3
2007 1
2008 3
2009 1
2010 5
2011 1
2012 6
2013 10
2014 16
2015 25
2016 13
2017 9
2018 18
2019 21
2020 22
2021 13
2022 25
2023 24
2024 7

Text availability

Article attribute

Article type

Publication date

Search Results

202 results

Results by year

Filters applied: . Clear all
Page 1
Did you mean youxiang ma (11 results)?
A wearable cardiac ultrasound imager.
Hu H, Huang H, Li M, Gao X, Yin L, Qi R, Wu RS, Chen X, Ma Y, Shi K, Li C, Maus TM, Huang B, Lu C, Lin M, Zhou S, Lou Z, Gu Y, Chen Y, Lei Y, Wang X, Wang R, Yue W, Yang X, Bian Y, Mu J, Park G, Xiang S, Cai S, Corey PW, Wang J, Xu S. Hu H, et al. Among authors: ma y. Nature. 2023 Jan;613(7945):667-675. doi: 10.1038/s41586-022-05498-z. Epub 2023 Jan 25. Nature. 2023. PMID: 36697864 Free PMC article.
First-in-human phase I/Ib study of QL1706 (PSB205), a bifunctional PD1/CTLA4 dual blocker, in patients with advanced solid tumors.
Zhao Y, Ma Y, Zang A, Cheng Y, Zhang Y, Wang X, Chen Z, Qu S, He J, Chen C, Jin C, Zhu D, Li Q, Liu X, Su W, Ba Y, Hao Y, Chen J, Zhang G, Qu S, Li Y, Feng W, Yang M, Liu B, Ouyang W, Liang J, Yu Z, Kang X, Xue S, Yang G, Yan W, Yang Y, Liu Z, Peng Y, Fanslow B, Huang X, Zhang L, Zhao H. Zhao Y, et al. Among authors: ma y. J Hematol Oncol. 2023 May 8;16(1):50. doi: 10.1186/s13045-023-01445-1. J Hematol Oncol. 2023. PMID: 37158938 Free PMC article. Clinical Trial.
Classification of Tumor Immune Microenvironment According to Programmed Death-Ligand 1 Expression and Immune Infiltration Predicts Response to Immunotherapy Plus Chemotherapy in Advanced Patients With NSCLC.
Sun D, Liu J, Zhou H, Shi M, Sun J, Zhao S, Chen G, Zhang Y, Zhou T, Ma Y, Zhao Y, Fang W, Zhao H, Huang Y, Yang Y, Zhang L. Sun D, et al. Among authors: ma y. J Thorac Oncol. 2023 Jul;18(7):869-881. doi: 10.1016/j.jtho.2023.03.012. Epub 2023 Mar 21. J Thorac Oncol. 2023. PMID: 36948245 Free article. Clinical Trial.
Phase I study of camrelizumab in patients with advanced solid tumors.
Ma Y, Cao J, Zhang Y, Liu Q, Fang W, Yang Y, Zhao Y, Yang Q, Zhao H, Zhang L. Ma Y, et al. Signal Transduct Target Ther. 2023 Feb 1;8(1):47. doi: 10.1038/s41392-022-01213-6. Signal Transduct Target Ther. 2023. PMID: 36725836 Free PMC article. Clinical Trial. No abstract available.
Ongoing Phase I Studies of Immune Checkpoint Inhibitors in China.
Fang W, Zhao S, Zhang Y, Ma Y, Zhao H, Zhang L. Fang W, et al. Among authors: ma y. Oncologist. 2019 Feb;24(Suppl 1):S11-S20. doi: 10.1634/theoncologist.2019-IO-S1-s03. Oncologist. 2019. PMID: 30819827 Free PMC article. Review.
A new histone deacetylase inhibitor remodels the tumor microenvironment by deletion of polymorphonuclear myeloid-derived suppressor cells and sensitizes prostate cancer to immunotherapy.
Chen Z, Yang X, Chen Z, Li M, Wang W, Yang R, Wang Z, Ma Y, Xu Y, Ao S, Liang L, Cai C, Wang C, Deng T, Gu D, Zhou H, Zeng G. Chen Z, et al. Among authors: ma y. BMC Med. 2023 Oct 25;21(1):402. doi: 10.1186/s12916-023-03094-0. BMC Med. 2023. PMID: 37880708 Free PMC article.
202 results